|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net income | ||||
| Adjustment to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation | ||||
| Right of use asset amortization | ||||
| Provision for (recovery of) credit losses | ||||
| Share-based compensation expense | ||||
| Net accretion of securities | ||||
| Fair value adjustment on equity securities | ||||
| Amortization of debt issuance costs | ||||
| Net loss (gain) on premises and equipment | ||||
| Losses on available-for-sale securities | ||||
| Deferred tax benefit | ||||
| Net increase in cash surrender value of life insurance | ||||
| Gain on sale of government guaranteed loans | ||||
| Changes in assets and liabilities: | ||||
| Decrease in accrued interest receivable | ||||
| Decrease in other assets | ||||
| Decrease in accrued interest payable | ||||
| Decrease in other liabilities | ||||
| Net cash provided by operating activities | ||||
| Cash Flows from Investing Activities | ||||
| Net (increase) in loans | ||||
| Net (increase) decrease in loans | ||||
| Proceeds from sale of government guaranteed loans originally classified as held for investment | ||||
| Proceeds from sale of available-for-sale securities | ||||
| Purchase of available-for-sale securities | ||||
| Proceeds from maturities, calls and principal repayments of available-for-sale securities | ||||
| Proceeds from maturities, calls and principal repayments of held-to-maturity securities | ||||
| Net (purchases) redemptions of restricted securities | ||||
| Net purchases of equity securities | ||||
| Net purchases of restricted securities | ||||
| Net sales (purchases) of equity securities | ||||
| Proceeds from bank owned life insurance contracts | ||||
| Net proceeds from equity securities | ||||
| Proceeds from sale of premises and equipment | ||||
| Purchases of bank premises and equipment | ||||
| Net cash (used in) provided by investing activities | ||||
| Cash Flows from Financing Activities | ||||
| Net increase (decrease) in deposits | ||||
| Net proceeds of Federal Home Loan Bank advances | ||||
| (Repayment of) proceeds from Federal Reserve Bank borrowings | ||||
| Repayment of Federal Reserve Bank borrowings | ||||
| Cash dividends paid | ||||
| Repayment of federal funds purchased | ||||
| Issuance of common stock for share options exercised | ||||
| Repurchase of shares for tax withholding on share-based compensation | ||||
| Repurchase of common stock | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of period | ||||
| Cash and cash equivalents, end of period | ||||
| Supplemental Disclosures of Cash Flow Information | ||||
| Interest | ||||
| Income taxes | ||||
| Income taxes - U.S. Federal | ||||
| Income taxes - U.S. State and Local | ||||
| Maryland | ||||
| Other | ||||
| Total income taxes paid | ||||
| Supplemental Disclosures of Noncash Transactions | ||||
| Unrealized gain on securities available-for-sale | ||||
| Right of use asset obtained in exchange for new operating lease liability | ||||
Loading...
